Petros Pharmaceuticals, Inc.
PTPI
$0.0919
-$0.0106-10.34%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 3.89M | 7.46M | 11.08M | 13.34M | 17.97M |
| Total Receivables | 1.95M | 1.78M | 1.96M | 2.23M | 2.98M |
| Inventory | 3.05M | 2.85M | 2.74M | 2.79M | 2.50M |
| Prepaid Expenses | 404.20K | 628.10K | 1.10M | 1.22M | 235.20K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 1.42M | 1.27M | 1.03M | 816.20K | 751.90K |
| Total Current Assets | 10.72M | 13.98M | 17.90M | 20.39M | 24.43M |
|
|
|||||
| Total Current Assets | 10.72M | 13.98M | 17.90M | 20.39M | 24.43M |
| Net Property, Plant & Equipment | 143.70K | 177.60K | 217.00K | 255.20K | 292.40K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 6.83M | 7.54M | 8.26M | 8.97M | 9.77M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 3.00M | 3.47M | 3.94M | 4.18M | 4.42M |
| Total Assets | 20.69M | 25.17M | 30.31M | 33.80M | 38.91M |
|
|
|||||
| Total Accounts Payable | 1.60M | 791.10K | 2.14M | 1.71M | 1.36M |
| Total Accrued Expenses | 2.98M | 1.95M | 2.60M | 3.23M | 2.38M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 2.33M | 1.94M | 1.55M | 1.28M | 1.29M |
| Total Finance Division Other Current Liabilities | 5.65M | 5.30M | 4.93M | 4.55M | 3.05M |
| Total Other Current Liabilities | 5.65M | 5.30M | 4.93M | 4.55M | 3.05M |
| Total Current Liabilities | 12.56M | 9.98M | 11.22M | 10.77M | 8.08M |
|
|
|||||
| Total Current Liabilities | 12.56M | 9.98M | 11.22M | 10.77M | 8.08M |
| Long-Term Debt | 4.92M | 5.70M | 6.46M | 6.86M | 7.25M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 91.80K | 107.80K | 123.00K | 137.70K | 151.40K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | 202.00K | 1.82M | 3.55M | 16.38M |
| Total Liabilities | 17.58M | 15.98M | 19.62M | 21.32M | 31.86M |
|
|
|||||
| Common Stock & APIC | 107.05M | 109.78M | 110.84M | 110.96M | 106.14M |
| Retained Earnings | -103.93M | -101.71M | -101.05M | -98.89M | -99.21M |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 3.12M | 8.07M | 9.79M | 12.07M | 6.93M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | 1.40K | 1.12M | 907.00K | 409.00K | 124.50K |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | 1.40K | 1.12M | 907.00K | 409.00K | 124.50K |
|
|
|||||
| Total Common Equity | 3.12M | 8.07M | 9.79M | 12.07M | 6.93M |
| Total Preferred Equity | 1.40K | 1.12M | 907.00K | 409.00K | 124.50K |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 3.12M | 9.19M | 10.69M | 12.48M | 7.06M |
|
|
|||||
